Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 10/20 | 0.45 |
| ▸ | PDE4A | P27815 | 7/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PTPRF | P10586 | 1/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18301582 | 0.88 | PDE4B (0.48) | PTPN1ALDH1A1KDM4EMAPTPDE4B | |
| SCHEMBL6876365 | 0.85 | ALDH1A1 (0.43) | PTPN1ALDH1A1KDM4EMAPTPDE4B | |
| SCHEMBL5673765 | 0.85 | PDE4B (0.47) | PTPN1ALDH1A1KDM4EMAPTPDE4B | |
| SCHEMBL5551730 | 0.83 | PDE4B (0.50) | PDE4BPDE4APDE4CPDE4D | |
| Levacetylleucine SCHEMBL15212381 | 0.82 | ATM (0.44) | PTPN1ALDH1A1PDE4BPDE4APDE4C | |
| SCHEMBL1223575 | 0.79 | KDM4E (0.53) | ALDH1A1KDM4EMAPTPDE4BPDE4A | |
| SCHEMBL3967066 | 0.78 | POLB (0.55) | PDE4BPDE4APDE4CPDE4D | |
| Hydrochloric Acid SCHEMBL9735815 | 0.77 | SMN1; SMN2 (0.49) | ALDH1A1KDM4EMAPTSMN1; SMN2LMNA | |
| SCHEMBL10325870 | 0.75 | PTGS2 (0.54) | KDM4EPDE4BSMN1; SMN2HTT | |
| SCHEMBL1971525 | 0.75 | PTPN1 (0.43) | PTPN1ALDH1A1KDM4EMAPTPDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117286121-A | Transaminase, and preparation method and application thereof | 江苏海洋大学 | 2023-12-26 | — | — | CN | claimed |
| EP-3280701-B1 | A METHOD OF CHIRAL RESOLUTION OF THE KEY INTERMEDIATE OF THE SYNTHESIS OF APREMILAST AND ITS USE FOR THE PREPARATION OF PURE APREMILAST | ZENTIVA KS (CZ) | 2019-10-16 | — | — | EP | claimed |
| EP-3307711-A1 | PROCESS FOR PREPARATION OF APREMILAST AND ITS INTERMEDIATES | Dr. Reddy's Laboratories Ltd. (IN) | 2018-04-18 | — | — | EP | claimed |
| EP-3286168-A1 | A SOLID FORM OF APREMILAST AND A PROCESS FOR PREPARING THE SAME | Zentiva K.S. (CZ) | 2018-02-28 | — | — | EP | claimed |
| WO-2016199031-A1 | PROCESS FOR PREPARATION OF APREMILAST AND ITS INTERMEDIATES | DR. REDDY’S LABORATORIES LIMITED (IN) | 2016-12-15 | — | — | WO | claimed |
| WO-2016169533-A1 | A SOLID FORM OF APREMILAST AND A PROCESS FOR PREPARING THE SAME | ZENTIVA, K.S. (CZ) | 2016-10-27 | — | — | WO | claimed |
| EP-1485087-A1 | (+)-2- 1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2004-12-15 | — | — | EP | claimed |
| WO-2003080048-A1 | (-)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2003-10-02 | — | — | WO | claimed |
| WO-2003080049-A1 | (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2003-10-02 | — | — | WO | claimed |
| EP-3619195-B1 | NOVEL PROCESS TO PREPARE N-[2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULPHONYL) ETHYL]-1, 3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL]ACETAMIDE | UNICHEM LAB LTD (IN) | 2025-07-23 | — | — | EP | disclosed |
| CN-118851979-A | Preparation method of apremilast | 潍坊市海欣药业有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-117286121-A | Transaminase, and preparation method and application thereof | 江苏海洋大学 | 2023-12-26 | — | — | CN | disclosed |
| EP-2651400-B2 | CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF | AMGEN EUROPE GMBH (CH) | 2023-01-18 | — | — | EP | disclosed |
| CN-112694426-B | Synthetic method of apremilast intermediate | 山东铂源药业股份有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-1485087-A1 | (+)-2- 1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1126839-A4 | SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNF ALPHA LEVELS | CELGENE CORP (US) | 2004-10-27 | — | — | EP | disclosed |
| WO-2003080049-A1 | (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2003-10-02 | — | — | WO | disclosed |
| WO-2003080048-A1 | (-)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE: METHODS OF USING AND COMPOSITIONS THEREOF | CELGENE CORPORATION (US) | 2003-10-02 | — | — | WO | disclosed |
| EP-1126839-A1 | SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNF ALPHA LEVELS | CELGENE CORPORATION (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2000025777-A1 | SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS | CELGENE CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |